middle.news
Optiscan Opens US FDA Review for InForm Digital Pathology Device
2:42pm on Thursday 1st of October, 2026 AEST
•
Medical Technology
Read Story
Optiscan Opens US FDA Review for InForm Digital Pathology Device
2:42pm on Thursday 1st of October, 2026 AEST
Key Points
510(k) submission lodged for InForm digital pathology device
Formal FDA review now begins, with no approval timetable disclosed
Slide-free imaging targets a largely analogue pathology workflow
Clinical studies and commercial readiness work will continue
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Optiscan Imaging (ASX:OIL)
OPEN ARTICLE